Emmerdale viewers point out problem with Bernice's health storyline The character has been struggling with her health recently and fans have spotted a problem in how she is handling it. Leeds Live · Nov 30, 2022
ITV Emmerdale viewers scream at TV as they uncover Bernice Blackstock's condition The character was worried she was showing signs of dementia Liverpool Echo · Nov 30, 2022
What is the difference between Alzheimer’s and dementia? New drug proven to slow onset of degenerative brain disease as scientists hail ‘breakthrough’ The Independent UK · Nov 30, 2022
New Alzeimher’s drug could offer major breakthrough in treating disease Scientists are optimistic about Lecanemab, which has slowed down cognitive decline in clinical trials Dublin Live · Nov 30, 2022
Drug proven to slow decline in Alzheimer patients Lecanemab, a newly developed drug, has showed promising results in clinical trials among Alzheimer patients Manchester Evening News · Nov 30, 2022
‘Momentous breakthrough’: New Alzheimer’s drug lives up to bold claims, with caveats Data supports claims that a new drug reduced cognitive and functional decline in Alzheimer's patients by 27 per cent in a clinical trial. The New Daily · Nov 30, 2022
NHS ‘nowhere near ready’ to deliver new Alzheimer’s drug, doctors say Patients unlikely to receive lecanemab before 2026 and health service does not yet have necessary infrastructure The Guardian - UK · Nov 30, 2022
It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough Recent lecanemab trials are reason for hope, although health services may struggle to deliver treatments, says dementia researcher Jonathan Schott The Guardian - UK · Nov 30, 2022
Lecanemab: new Alzheimer’s drug hailed as ‘beginning of the end’ for disease A ground-breaking drug has been found to slow cognitive decline in people with Alzheimer’s - with experts hailing it a breakthrough that “can meaningfully change the course of the disease”. Evening Standard · Nov 30, 2022
Breakthrough Alzheimer's drug hailed as 'beginning of the end' for treating disease Lecanemab was found to have reduced memory decline by targeting and clearing amyloid, which is one of the proteins that build up in the brains of people with the disease Daily Mirror · Nov 30, 2022
Simple urine test could be used to diagnose early-stage Alzheimer’s disease The early stage of the disease occurs before the irreversible dementia stage and is the golden window for intervention and treatment Wales Online · Nov 30, 2022
New Alzheimer’s drug hailed as 'beginning of the end' in quest for treatment Clinical results suggest that the disease progression can by slowed by 27% Wales Online · Nov 30, 2022
New Alzheimer’s drug hailed as ‘beginning of the end’ in search for treatment Lecanemab was found to slow decline in patients’ memory and thinking. The Independent UK · Nov 30, 2022
Scientists hail major breakthrough in fight against Alzheimer’s as drug proven to slow disease ‘This is the first drug that provides a real treatment option,’ says leading researcher The Independent UK · Nov 30, 2022
The Guardian - UK · Nov 30, 2022 Drug slows cognitive decline in Alzheimer’s patients, study reveals Antibody therapy lecanemab removes clumps of protein called beta amyloid that builds up in brain
Tribune News Service · Nov 29, 2022 Supreme Court case could curtail rights of Medicaid patients Gorgi Talevski did not live long enough to see his case argued before the U.S. Supreme Court this month. A Macedonian-born resident of Indiana, Talevski operated a crane for three decades, raised a family and loved to dance before his dementia deepened, and he died last year.
Daily Record · Nov 29, 2022 Former St Mirren defender Barry McLaughlin welcomes new heading rules amid brain disease fears for players The SFA have brought in new guidance to limit the amount of heading in training after research found footballers were more likely to suffer from brain disease in later life.
Daily Record · Nov 29, 2022 Family of Scots football hero Gordon McQueen back SFA crackdown on heading balls The Manchester United powerhouse is now bedridden and unable to communicate after being diagnosed with vascular dementia last year.
Daily Record · Nov 29, 2022 SFA's new guidelines on restricting headers in football training are welcome Record View says it has been heartbreaking in recent years to see many football legends have their lives cruelly blighted by dementia.
Wales Online · Nov 28, 2022 Council announces £60 million plans for care homes in RCT It will involve creating extra care accommodation and dementia beds, closing three care homes, keeping five open and providing a care facility for adults with learning disabilities
Wales Online · Nov 25, 2022 Five symptoms of dementia and the early warning signs to watch out for One study has revealed that as many as one in four sufferers go at least two years before being diagnosed
Daily Mirror · Nov 24, 2022 Tony Robinson says UK care system is in chaos after looking after parents with dementia More than 700,000 people in the UK are unpaid carers for those with dementia and tackle intractable problems all year round, but many soon face poverty and little or no respite
Daily Mirror · Nov 24, 2022 Real Britain: 'Our care system in chaos as those who depend on it face the consequences' More than 700,000 people in the UK are unpaid carers for those with dementia and tackle intractable problems all year round, but many soon face poverty and little or no respite
The Conversation · Nov 24, 2022 Chris Hemsworth's Alzheimer's gene doesn't guarantee he'll develop dementia. Here's what we can all do to reduce our risk Chris Hemsworth, famous for his role as the god Thor in Marvel Cinematic Universe movies, has announced he will be taking a break from acting after being told he has two copies of the APOE4 gene, increasing his risk of Alzheimer’s.
Daily Mirror · Nov 23, 2022 Alzheimer's disease could be slowed down by new drug as NHS urged to speed up testing Lecanemab could mark 'the end of the beginning' in the decades-long fight against dementia, geneticist Prof Sir John Hardy said. The drug was found to reduce brain decline in those with mild dementia